Governance Health Outcomes Pharmaceutical Industry 
Healthcare IT Today
JANUARY 23, 2023
He has 30+ years of business experience, with 20 years in the healthcare and pharmaceutical industries. Today Velsera comprises three global, industry leading organizations in the healthcare and life science industries: Pierian, Seven Bridges, and UgenTec, and growth and expansion should be expected in 2023 and beyond.
Healthcare IT Today
JANUARY 23, 2024
global lead of the Accenture Life Sciences business, said, “Through our investment in QuantHealth, we are further solidifying our commitment to utilizing advanced technologies to bring revolutionary change in the pharmaceutical industry. Petra Jantzer, Ph.D., Terms of the investment were not disclosed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
HIT Consultant
AUGUST 30, 2023
AI also has the potential to identify, and even design, up to 50 new therapeutic drugs in the next decade, representing a $ 50 billion opportunity for the global pharmaceutical industry, with a 20-40% reduction in pre-clinical costs. Ensuring transparency, accountability, and patient autonomy must be prioritized.
HIT Consultant
AUGUST 12, 2024
Austin-based Cartmell has 25 yearsof experience in healthcare as a Chief Operating Officer, Chief Revenue Officer, board member and VC investor, as well as an advisor to Morgan Stanley, UnitedHealthcare, the University of Texas at Austin Dell Medical School and the British Government.
Expert insights. Personalized for you.
107 
Let's personalize your content